Bionano Genomics, Inc. (BNGO) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Bionano Genomics, Inc. (BNGO) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $13.4M, listed on NASDAQ, employing roughly 96 people, carrying a beta of 1.62 to the broader market. Bionano Genomics, Inc. Led by Albert A. Luderer, public since 2018-08-21.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for BNGO as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →